{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:45:38Z","timestamp":1791229538745,"version":"4.1.0"},"reference-count":103,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"vor","delay-in-days":3412,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2010]]},"DOI":"10.1097\/wox.0b013e3181e2eb2e","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T10:48:52Z","timestamp":1276166932000},"page":"202-215","source":"Crossref","is-referenced-by-count":10,"title":["Dermatology for the Allergist"],"prefix":"10.1016","volume":"3","author":[{"given":"Dennis","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0005","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1067\/mjd.2000.107773","article-title":"The prevalence of atopic dermatitis in Oregon schoolchildren","volume":"43","author":"Laughter","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0010","unstructured":"Georg R. Atopic Dermatitis. London: Saunders; 1975."},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2340\/00015555736263","article-title":"Descendant family history of atopic dermatitis","volume":"73","author":"Uehara","year":"1993","journal-title":"Acta Derm Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.molmed.2007.10.006","article-title":"The filaggrin story: novel insights into skin-barrier function and disease","volume":"14","author":"McGrath","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0025","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.0022-202X.2004.22708.x","article-title":"Genetic association between an AACC insertion in the 3\u2032UTR of the stratum corneum chymotryptic enzyme gene and atopic dermatitis","volume":"123","author":"Vasilopoulos","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0030","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/ng728","article-title":"Gene polymorphism in Netherton and common atopic disease","volume":"29","author":"Walley","year":"2001","journal-title":"Nat Genet"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0035","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jaci.2008.03.027","article-title":"Antimicrobial peptides and the skin immune defense system","volume":"122","author":"Schauber","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0040","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jaci.2007.11.029","article-title":"The toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis","volume":"121","author":"Mrabet-Dahbi","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0045","doi-asserted-by":"crossref","unstructured":"Fonacier LS, Dreskin SC, Leung DY: Allergic skin diseases. J Allergy Clin Immunol. 125: S138-S149.","DOI":"10.1016\/j.jaci.2009.05.039"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0050","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/archderm.1961.01580120027005","article-title":"Pityriasis alba: a form of atopic dermatitis. A preliminary report","volume":"83","author":"Watkins","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1468-3083.2002.00494.x","article-title":"Pityriasis alba: a study of pathogenic factors","volume":"16","author":"Blessmann Weber","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0060","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/j.1365-4362.1993.tb01401.x","article-title":"Pityriasis alba: a histologic study","volume":"32","author":"Vargas-Ocampo","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0065","first-page":"284","article-title":"Allergic contact dermatitis","volume":"14","author":"Saint-Mezard","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0070","first-page":"i","article-title":"Skin conditions and related need for medical care among persons 1-74 years. United States, 1971-1974","volume":"11","author":"Johnson","year":"1978","journal-title":"Vital Health Stat"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199306103282304","article-title":"Cutaneous disease and drug reactions in HIV infection","volume":"328","author":"Coopman","year":"1993","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1097\/WOX.0b013e3181e2eb2e_bib0080","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/00042560-199801001-00008","article-title":"The Western Australian HIV Cohort Study, Perth, Australia","volume":"17","author":"Mallal","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0733-8635(03)00028-7","article-title":"Seborrheic dermatitis","volume":"21","author":"Gupta","year":"2003","journal-title":"Dermatol Clin"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0090","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJMcp0806464","article-title":"Clinical practice. Seborrheic dermatitis","volume":"360","author":"Naldi","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0095","first-page":"125","article-title":"Seborrheic dermatitis: an overview","volume":"74","author":"Schwartz","year":"2006","journal-title":"Am Fam Physician"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00128071-200708040-00005","article-title":"Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study","volume":"8","author":"C\u00f6mert","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1177\/039463200501800418","article-title":"Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study","volume":"18","author":"Vena","year":"2005","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0110","first-page":"16","article-title":"Oral therapy for rosacea","volume":"5","author":"Baldwin","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0115","first-page":"19","article-title":"Subantimicrobial dose doxycycline: a unique treatment for rosacea","volume":"75","author":"Berman","year":"2005","journal-title":"Cutis"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0120","first-page":"97","article-title":"Update on rosacea pathogenesis and correlation with medical therapeutic agents","volume":"78","author":"Del Rosso","year":"2006","journal-title":"Cutis"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0125","first-page":"S12","article-title":"Advances in the topical treatment of acne and rosacea","volume":"3","author":"Ceilley","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0130","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1159\/000082564","article-title":"Rosacea: an update","volume":"210","author":"Buechner","year":"2005","journal-title":"Dermatology"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0135","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1473-2165.2002.00071.x","article-title":"Laser treatment of rosacea","volume":"1","author":"Laube","year":"2002","journal-title":"J Cosmet Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0140","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1468-3083.2005.01216.x","article-title":"Rosacea and its management: an overview","volume":"19","author":"Gupta","year":"2005","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0145","first-page":"8","article-title":"Rosacea: clinical presentation and pathophysiology","volume":"5","author":"Diamantis","year":"2006","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0150","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1067\/mjd.2002.120625","article-title":"Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea","volume":"46","author":"Wilkin","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1046\/j.1523-1747.2001.01340.x","article-title":"Cutaneous injury induces the release of cathelicidin antimicrobial peptides active against group A Streptococcus","volume":"117","author":"Dorschner","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0160","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm1616","article-title":"Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Yamasaki","year":"2007","journal-title":"Nat Med"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0165","doi-asserted-by":"crossref","first-page":"11035","DOI":"10.1073\/pnas.91.23.11035","article-title":"Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds","volume":"91","author":"Gallo","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0170","doi-asserted-by":"crossref","unstructured":"Yamasaki K, Gallo RL. The molecular pathology of rosacea. J Dermatol Sci. 2009.","DOI":"10.1016\/j.jdermsci.2009.04.007"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0175","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/S0190-9622(99)70085-X","article-title":"A comparison of topical azelaic acid 20% cream and topical metronidazole 0.75% cream in the treatment of patients with papulo-pustular rosacea","volume":"40","author":"Maddin","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0180","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1001\/archderm.139.11.1444","article-title":"A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial","volume":"139","author":"Elewski","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0185","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1080\/000155599750009906","article-title":"Double-blind comparison of azelaic acid 20% cream and its vehicle in treatment of papulo-pustular rosacea","volume":"79","author":"Bjerke","year":"1999","journal-title":"Acta Derm Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2133.1983.tb03993.x","article-title":"A double-blind study of I% metronidazole cream versus systemic oxytetracycline therapy for rosacea","volume":"109","author":"Nielsen","year":"1983","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0195","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1067\/mjd.2003.308","article-title":"Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies","volume":"48","author":"Thiboutot","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.1980.tb06558.x","article-title":"A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea","volume":"102","author":"Saihan","year":"1980","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0205","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(71)90376-X","article-title":"Comparative effectiveness of tetracycline and ampicillin in rosacea. A controlled trial","volume":"2","author":"Marks","year":"1971","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0210","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2133.1966.tb12168.x","article-title":"A clinical trial of tetracycline in rosacea","volume":"78","author":"Sneddon","year":"1966","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jaad.2006.04.084","article-title":"Systematic review of rosacea treatments","volume":"56","author":"van Zuuren","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0220","series-title":"Clinical Dermatology: A Color Guide to Diagnosis and Therapy","author":"Thomas","year":"2004"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0225","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1159\/000245991","article-title":"Human herpesvirus 7 in patients with pityriasis rosea. Electron microscopy investigations and polymerase chain reaction in mononuclear cells, plasma and skin","volume":"195","author":"Drago","year":"1997","journal-title":"Dermatology"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0230","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1747.2002.00200.x","article-title":"Pityriasis rosea is associated with systemic active infection with both human herpesvirus-7 and human herpesvirus-6","volume":"119","author":"Watanabe","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0235","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/j.0022-202X.2005.23719.x","article-title":"Additional evidence that pityriasis rosea is associated with reactivation of human herpesvirus-6 and -7","volume":"124","author":"Broccolo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0240","first-page":"87","article-title":"Pityriasis rosea","volume":"69","author":"Stulberg","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0245","series-title":"Dermatology in general medicine","author":"Bjornberg","year":"1999"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0250","unstructured":"Dermatology in General Medicine. 1993, New York: Mcgraw-Hill, 4"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0255","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0190-9622(00)90132-4","article-title":"Erythromycin in pityriasis rosea: A double-blind, placebo-controlled clinical trial","volume":"42","author":"Sharma","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0260","doi-asserted-by":"crossref","unstructured":"Chuh AA, Dofitas BL, Comisel GG, Reveiz L, Sharma V, Garner SE, et al. Interventions for pityriasis rosea. Cochrane Database Syst Rev. 2007:CD005068.","DOI":"10.1002\/14651858.CD005068.pub2"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0265","first-page":"35","article-title":"Oral erythromycin is ineffective in the treatment of pityriasis rosea","volume":"7","author":"Rasi","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0270","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1542\/peds.2005-2450","article-title":"Azithromycin does not cure pityriasis rosea","volume":"117","author":"Amer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaad.2005.06.042","article-title":"Use of high-dose acyclovir in pityriasis rosea","volume":"54","author":"Drago","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0280","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1610-0387.2007.06274.x","article-title":"Pathophysiology of acne","volume":"5","author":"Degitz","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0285","doi-asserted-by":"crossref","first-page":"e1000527","DOI":"10.1371\/journal.ppat.1000527","article-title":"Production of superoxide anions by keratinocytes initiates P. acnes-induced inflammation of the skin","volume":"5","author":"Grange","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0290","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2133.2004.05762.x","article-title":"Proinflammatory cytokine production by human keratinocytes stimulated with Propionibacterium acnes and P. acnes GroEL","volume":"150","author":"Graham","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0295","first-page":"615","article-title":"Pathogenesis of acne vulgaris: recent advances","volume":"8","author":"Bhambri","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0300","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2133.2005.06933.x","article-title":"Induction of toll-like receptors by Propionibacterium acnes","volume":"153","author":"Jugeau","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0305","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jaad.2006.08.048","article-title":"Guidelines of care for acne vulgaris management","volume":"56","author":"Strauss","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0310","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.det.2007.01.012","article-title":"Anti-inflammatory activity of tetracyclines","volume":"25","author":"Webster","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0315","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaad.2005.10.004","article-title":"Tetracyclines: nonantibiotic properties and their clinical implications","volume":"54","author":"Sapadin","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0320","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2133.2003.05067.x","article-title":"Antibiotic-resistant acne: lessons from Europe","volume":"148","author":"Ross","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0325","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.306.6877.555","article-title":"Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage","volume":"306","author":"Eady","year":"1993","journal-title":"BMJ"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0330","first-page":"130","article-title":"Lymecycline in the treatment of acne: an efficacious, safe and cost-effective alternative to minocycline","volume":"13","author":"Bossuyt","year":"2003","journal-title":"Eur J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0335","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0340","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-4362.2000.00749.x","article-title":"Azithromycin for the treatment of acne","volume":"39","author":"Fernandez-Obregon","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0345","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-4632.2004.02058.x","article-title":"Acne treated successfully with azithromycin","volume":"43","author":"Kapadia","year":"2004","journal-title":"Int J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0350","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1529-8019.2008.00175.x","article-title":"New and emerging treatments in dermatology: acne","volume":"21","author":"Katsambas","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0355","first-page":"1415","article-title":"Common tinea infections in children","volume":"77","author":"Andrews","year":"2008","journal-title":"Am Fam Physician"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0360","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1542\/pir.28-5-164","article-title":"Tinea corporis and tinea capitis","volume":"28","author":"Shy","year":"2007","journal-title":"Pediatr Rev"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0365","first-page":"101","article-title":"Dermatophyte infections","volume":"67","author":"Hainer","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0370","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0190-9622(85)70142-9","article-title":"Familial lichen planus. More frequent than previously suggested?","volume":"13","author":"Kofoed","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0375","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.1986.tb02852.x","article-title":"An association between HLA DRI and lichen planus","volume":"114","author":"Powell","year":"1986","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0380","doi-asserted-by":"crossref","first-page":"615","DOI":"10.7326\/0003-4819-123-8-199510150-00008","article-title":"Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations","volume":"123","author":"Gumber","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0385","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jaad.2004.01.002","article-title":"Oral lichen planus, hepatitis C virus, and HIV: no association in a cohort study from an area of high hepatitis C virus endemicity","volume":"51","author":"Campisi","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0390","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1085-5629(98)80012-6","article-title":"Vulvar dermatoses: lichen sclerosus, lichen planus, and vulval dermatitis\/lichen simplex chronicus","volume":"17","author":"Ball","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0395","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-0714.1985.tb00516.x","article-title":"Lichen planus: review and update on pathogenesis","volume":"14","author":"Scully","year":"1985","journal-title":"J Oral Pathol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0400","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1067\/mjd.2000.108319","article-title":"Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid","volume":"43","author":"Lebwohl","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0405","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/0190-9622(91)70067-C","article-title":"Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients","volume":"24","author":"Laurberg","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0410","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0190-9622(84)80312-6","article-title":"Bilateral comparison of generalized lichen planus treated with psoralens and ultraviolet A","volume":"10","author":"Gonzalez","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0415","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1365-2230.1996.tb00015.x","article-title":"Erosive and generalized lichen planus responsive to azathioprine","volume":"21","author":"Lear","year":"1996","journal-title":"Clin Exp Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0420","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0190-9622(90)70009-7","article-title":"Treatment of severe lichen planus with cyclosporine","volume":"22","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0425","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1601-0825.1999.tb00063.x","article-title":"Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide","volume":"5","author":"Carbone","year":"1999","journal-title":"Oral Dis"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0430","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0030-4220(93)90091-H","article-title":"Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study","volume":"75","author":"Vo\u00fbte","year":"1993","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0435","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1067\/mjd.2002.120922","article-title":"Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus","volume":"47","author":"Hegarty","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0440","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1601-0825.1999.tb00301.x","article-title":"The management of oral lichen planus","volume":"5","author":"Carrozzo","year":"1999","journal-title":"Oral Dis"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0445","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/sder.2001.29061","article-title":"Tacrolimus clinical studies for atopic dermatitis and other conditions","volume":"20","author":"Bergman","year":"2001","journal-title":"Semin Cutan Med Surg"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0450","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(77)90288-4","article-title":"Treatment of erosive lichen planus of the oral mucosa with depot steroids","volume":"2","author":"Ferguson","year":"1977","journal-title":"Lancet"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0455","doi-asserted-by":"crossref","first-page":"366","DOI":"10.2340\/0001555566366367","article-title":"Treatment of erosive lichen planus with dapsone","volume":"66","author":"Beck","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0460","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0190-9622(85)70080-1","article-title":"Dapsone in the treatment of erosive lichen planus","volume":"12","author":"Falk","year":"1985","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0465","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0190-9622(93)70082-5","article-title":"Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: an open trial","volume":"28","author":"Eisen","year":"1993","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0470","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0030-4220(91)90007-Y","article-title":"A prospective study of findings and management in 214 patients with oral lichen planus","volume":"72","author":"Silverman","year":"1991","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0475","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2133.1995.tb00728.x","article-title":"Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial","volume":"132","author":"Sieg","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0480","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0733-8635(05)70143-1","article-title":"New and emerging therapies for lichenoid dermatoses","volume":"18","author":"Boyd","year":"2000","journal-title":"Dermatol Clin"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0485","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archderm.143.4.511","article-title":"Oral lichen planus: a case series with emphasis on therapy","volume":"143","author":"Torti","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0490","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1468-3083.2006.01832.x","article-title":"Successful treatment of oral erosive lichen planus with mycophenolate mofetil","volume":"21","author":"Dalmau","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0495","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0190-9622(03)02111-X","article-title":"Treatment of severe lichen planus with mycophenolate mofetil","volume":"49","author":"Frieling","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0500","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.en.13.010168.001033","article-title":"The allergic response to biting insects","volume":"13","author":"Feingold","year":"1968","journal-title":"Ann Rev Entomol"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0505","first-page":"171","article-title":"Analysis of dermatological manifestations following blackfly (Simuliidae) bites as observed in the years 1981-1983 in Bratislava (Czechoslovakia)","volume":"32","author":"Simuliosis","year":"1984","journal-title":"Derm Beruf Umwelt 1984"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0510","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa011699","article-title":"Comparative efficacy of insect repellents against mosquito bites","volume":"347","author":"Fradin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1097\/WOX.0b013e3181e2eb2e_bib0515","first-page":"7","article-title":"Beyond spaghetti and meatballs: skin diseases associated with the Malassezia yeasts","volume":"21","author":"Levin","year":"2009","journal-title":"Dermatol Nurs"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119304776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119304776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:26:07Z","timestamp":1711549567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119304776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":103,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010]]}},"alternative-id":["S1939455119304776"],"URL":"https:\/\/doi.org\/10.1097\/wox.0b013e3181e2eb2e","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}